Screening and identification of key genes involved in lymphatic metastasis of oral squamous cell carcinoma

Ying CHEN; Li LUO; Yajing ZHONG; Qin ZENG

doi:10.16016/j.1000-5404.201901143

您当前的位置：

首页 >

文章列表页 >

Screening and identification of key genes involved in lymphatic metastasis of oral squamous cell carcinoma

Basic Medicine | 更新时间：2026-01-09

- Screening and identification of key genes involved in lymphatic metastasis of oral squamous cell carcinoma
- Journal of Third Military Medical University Vol. 41, Issue 12, Pages: 1149-1155(2019)
- 作者机构：
  
  1.400014 重庆，重庆市人民医院口腔科
  2.400037 重庆，陆军军医大学(第三军医大学)第二附属医院口腔科
- 作者简介：
- 基金信息：
- DOI：10.16016/j.1000-5404.201901143
  CLC： R318.04;R73-37;R739.85
- Received：17 January 2019，
  
  Revised：2019-03-10，
  
  Published：30 June 2019
- 稿件说明：
移动端阅览
Ying CHEN, Li LUO, Yajing ZHONG, et al. Screening and identification of key genes involved in lymphatic metastasis of oral squamous cell carcinoma[J]. Journal of Third Military Medical University, 2019, 41(12): 1149-1155.
DOI：

Ying CHEN, Li LUO, Yajing ZHONG, et al. Screening and identification of key genes involved in lymphatic metastasis of oral squamous cell carcinoma[J]. Journal of Third Military Medical University, 2019, 41(12): 1149-1155. DOI： 10.16016/j.1000-5404.201901143.

摘要

目的

筛选口腔鳞状细胞癌(oral squamous cell carcinoma，OSCC)发生淋巴转移的关键基因，并对其进行生物信息学分析及鉴定。

方法

从基因表达数据库(gene expression omnibus，GEO)中下载OSCC表达谱芯片GSE2280，利用在线工具GEO2R对表达差异基因(differentially expressed genes，DEGs)进行筛选。基于DAVID数据库对DEGs进行GO分析及KEGG通路分析，运用STRING数据库及Cytoscape软件构建蛋白相互作用网络。使用CytoHubba插件鉴定枢纽基因，并使用肿瘤基因图谱数据库(the cancer genome atlas，TCGA)在口腔肿瘤病例中进行枢纽基因突变的生存分析比较。

结果

在OSCC发生淋巴转移与未发生淋巴转移的患者中共筛选出131个DEGs，其中74个上调基因，57个下调基因。上调基因GO功能主要富集在消化降解(GO:0007586)、中间丝细胞骨架(GO:0045111)、受损的DNA结合(GO:0003684)，主要参与胰腺分泌(hsa04972)和代谢途径(hsa01100)，下调基因GO功能富集在细胞外基质组成(GO:0030198)、胶原三聚体(GO:0005581)和细胞外基质结构成分(GO:0005201)，主要参与细胞外基质受体相互作用(hsa04512)及蛋白质消化吸收(hsa04974)。关键的枢纽基因包括：DHCR24、ALDH3A1、COL5A1、HSPG2、APOE、TP63、VCAN。枢纽基因分析结果显示：TP63突变的患者出现生存率降低的趋势(

=0.717)，VCAN突变的患者呈现生存率升高的趋势(

=0.568)，但生存率差异均无统计学意义。

结论

DHCR24、ALDH3A1、COL5A1、HSPG2、APOE、TP63、VCAN关键基因在OSCC淋巴转移中具有潜在的基础和临床研究价值。

Abstract

Objective

To screen the key genes associated with lymphatic metastasis of oral squamous cell carcinoma (OSCC) and analyze their roles and the impact of their mutations on the patients' survival through a bioinformatics approach.

Methods

The OSCC expression profile chip GSE2280 was downloaded from GEO database

and the differentially expressed genes (DEGs) were screened using the online tool GEO2R. Based on DAVID database

GO analysis and KEGG pathway analysis of the DEGs were carried out

and the protein interaction network was constructed using STRING database and Cytoscape software. CytoHubba Plug-in was used to identify the hub genes

and The Cancer Genome Atlas (TCGA) database was used to analyze the survival outcomes of oral cancer patients with mutations of these hub genes.

Results

We identified a total of 131 DEGs

including 74 up-regulated and 57 down-regulated genes

between OSCC patients with lymphatic metastasis and those without lymphatic metastasis. The up-regulated genes were enriched in digestion and degradation (GO:0007586)

intermediate filament cytoskeleton (GO:0045111)

and impaired DNA binding (GO:0003684)

and participated mainly in pancreatic secretion (hsa04972) and metabolic pathway (hsa01100). The down-regulated genes were enriched in extracellular matrix composition (GO:0030198)

collagen trimer (GO:0005581) and extracellular matrix structural components (GO:0005201)

and participated in extracellular matrix receptor interaction (hsa04512) and protein digestion and absorption (hsa04974). The key hub genes involved in lymphatic metastasis of OSCC included DHCR24

ALDH3A1

COL5A1

HSPG2

APOE

TP63 and VCAN. Analysis of the data from TCGA database showed that the survival rate of patients with TP63 mutation was significantly decreased (

=0.717)

and the patients with VCAN mutation appeared to have an increased survival rate

but this increase was not statistically significant (

=0.568).

Conclusion

DHCR24

ALDH3A1

COL5A1

HSPG2

APOE

TP63 and VCAN genes may have potential values in both preclinical and clinical studies of lymphatic metastasis of OSCC.

关键词

Keywords

references

WARNAKULASURIYA S. Living with oral cancer: epidemi-ology with particular reference to prevalence and life-style changes that influence survival[J]. Oral Oncol, 2010, 46(6): 407-410. DOI: 10.1016/j.oraloncology.2010.02.015.

SEVERINO P, OLIVEIRA L S, ANDREGHETTO F M, et al. Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma[J]. BMC Med Genomics, 2015, 8: 31. DOI: 10.1186/s12920-015-0102-4.

LAIMER K, BLASSNIG N, SPIZZO G, et al. Prognostic significance of 14-3-3sigma expression in oral squamous cell carcinoma (OSCC)[J]. Oral Oncol, 2009, 45(2): 127-134. DOI: 10.1016/j.oraloncology.2008.04.006.

TORUNER G A, ULGER C,ALKAN M, et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma[J]. Cancer Genet Cytogenet, 2004, 154(1): 27-35. DOI: 10.1016/j.cancergencyto.2004.01.026.

HSIA K T, LIU C J, MAR K, et al. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma[J]. Head Neck, 2016, 38(4): 550-559. DOI: 10.1002/hed.23927.

TATANGELO F, DI MAURO A, SCOGNAMIGLIO G, et al. Posterior HOX genes and HOTAIR expression in the proximal and distal colon cancer pathogenesis[J]. J Transl Med, 2018, 16(1): 350. DOI: 10.1186/s12967-018-1725-y.

BELACEL N, WANG Q, CUPERLOVIC-CULF M. Clustering methods for microarray gene expression data[J]. OMICS, 2006, 10(4): 507-531. DOI: 10.1089/omi.2006.10.507.

O'DONNELL R K, KUPFERMAN M, WEI S J, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity[J]. Oncogene, 2005, 24(7): 1244-1251. DOI: 10.1038/sj.onc.1208285.

SZKLARCZYK D, MORRIS J H, COOK H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible[J]. Nucleic Acids Res, 2017, 45(D1): D362-D368. DOI: 10.1093/nar/gkw937.

KOHL M, WIESE S, WARSCHEID B. Cytoscape: software for visualization and analysis of biological networks[J]. Methods Mol Biol, 2011, 696: 291-303. DOI: 10.1007/978-1-60761-987-1_18.

CHIN C H, CHEN S H, WU H H, et al. CytoHubba: identifying hub objects and sub-networks from complex interactome[J]. BMC Syst Biol, 2014, 8(Suppl 4): S11. DOI: 10.1186/1752-0509-8-S4-S11.

LIU H, LI J J, YANG Y, et al. Alterations of 63 hub genes during lingual carcinogenesis in C57BL/6J mice[J]. Sci Rep, 2018, 8(1): 12626. DOI: 10.1038/s41598-018-31103-3.

PEDRO N F, BISELLI J M, MANIGLIA J V, et al. Candidate biomarkers for oral squamous cell carcinoma: differential expression of oxidative stress-related genes[J]. Asian Pac J Cancer Prev, 2018, 19(5): 1343-1349. DOI: 10.22034/APJCP.2018.19.5.1343.

DAI M, ZHU X L, LIU F, et al. Cholesterol synthetase DHCR24 induced by insulin aggravates cancer invasion and progesterone resistance in endometrial carcinoma[J]. Sci Rep, 2017, 7: 41404. DOI: 10.1038/srep41404.

YAN J, DE MELO J, CUTZ J C, et al. Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis[J]. Br J Cancer, 2014, 110(10): 2593-2603. DOI: 10.1038/bjc.2014.201.

LI G, LI X, YANG M, et al. Prediction of biomarkers of oral squamous cell carcinoma using microarray technology[J]. Sci Rep, 2017, 7: 42105. DOI: 10.1038/srep42105.

GRINDEL B J, MARTINEZ J R, TELLMAN T V, et al. Matrilysin/MMP-7 cleavage of Perlecan/HSPG2 complexed with semaphorin 3A supports FAK-mediated stromal invasion by prostate cancer cells[J]. Sci Rep, 2018, 8(1): 7262. DOI: 10.1038/s41598-018-25435-3.

GRINDEL B, LI Q L, ARNOLD R, et al. Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients[J]. Oncotarget, 2016, 7(37): 60775. DOI: 10.18632/oncotarget.11976.

JAYAKAR S K, LOUDIG O, BRANDWEIN-GENSLER M, et al. Apolipoprotein E promotes invasion in oral squamous cell carcinoma[J]. Am J Pathol, 2017, 187(10): 2259-2272. DOI: 10.1016/j.ajpath.2017.06.016.

ZHUANG Z, XIE N, HU J, et al. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma[J]. Oncotarget, 2017, 8(13): 21954-21973. DOI: 10.18632/oncotarget.15752.

ABRAM T J, PICKERING C R, LANG A K, et al. Risk stratification of oral potentially malignant disorders in fanconi anemia patients using autofluorescence imaging and cytology-on-a chip assay[J]. Transl Oncol, 2018, 11(2): 477-486. DOI: 10.1016/j.tranon.2018.01.014.

ZHANG Y, ZOU X, QIAN W, et al. EnhancedPAPSS2/VCAN sulfation axis is essential for Snail-mediated breast cancer cell migration and metastasis[J]. Cell Death Differ, 2019, 26(3): 565-579. DOI: 10.1038/s41418-018-0147-y.

SALEM M, O'BRIEN J A, BERNAUDO S, et al. miR-590-3p promotes ovarian cancer growth and metastasis via a novel FOXA2-versican pathway[J ] . Cancer Res, 2018, 78(15): 4175-4190. DOI: 10.1158/0008-5472.CAN-17-3014.

LIU X G, HAN C Y, LIAO X W, et al. Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma[J]. Cancer Manag Res, 2018, 10: 1027-1036. DOI: 10.2147/CMAR.S161906.

MITSUI Y, SHIINA H, KATO T, et al. Versican promotes tumor progression, metastasis and predicts poor prognosis in renal carcinoma[J]. Mol Cancer Res, 2017, 15(7): 884-895. DOI: 10.1158/1541-7786.MCR-16-0444.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

DLGAP5 promotes progression of oral squamous cell carcinoma by regulating the Warburg effect

Expression of β-arrestin1 in oral squamous cell carcinoma and its effect on cell proliferation, migration and invasion

Features of tumor cells and microenvironment associated with recurrence risk of mesenchymal-subtype gastric cancer based on bulk RNA-seq and scRNA-seq

Screening of pyroptosis-related long non-coding RNAs and genes that influence prognosis for colon cancer

Significance of transcription factor LMO3 in evaluating prognosis of patients with endometrial carcinoma

Related Author

ZHANG Qingzi

GUO Foqing

CHEN Yongqin

XIA Feifei

LUO Jun

LIU Zhe

ZHA Xiaoyu

LI Changxue

Related Institution

Department of Oral and Maxillofacial Surgery， the First Affiliated Hospital of Shihezi University

School of Medicine， Shihezi University

Department of Oral and Maxillofacial Surgery， Jinan Third People’s Hospital

Department of Stomatology， the First Affiliated Hospital of Shihezi University

Department of Gastroenterology， Chongqing University Cancer Hospital

⁰